期刊文献+

抗坏血酸抗肿瘤作用机制的研究进展 被引量:3

Advances in research of the anti-cancer mechanism of ascorbic acid
原文传递
导出
摘要 抗坏血酸在国外作为一种辅助抗肿瘤治疗药物,已经使用多年。尽管一直未被主流医学所接纳,但在最近的10年,越来越多的体外试验和动物实验得出相同的结论,一致认为药理浓度的抗坏血酸能选择性杀灭肿瘤细胞。就不同途径、不同剂量下的抗坏血酸对肿瘤细胞的影响作一综述。 In foreign countries, ascorbic acid (vitamin C) has been used as a complementary drug in cancer treatments for many years. Although it has not been accepted by mainstream medicine, a growing number of in vitro and in vivo experiments indicated that pharmacological concentrations of ascorbie acid could inhibited cancer cell proliferation and promote cell apoptosis. In this paper, the anti-cancer effect of ascorbic acid weer reviewed.
出处 《肿瘤研究与临床》 CAS 2012年第12期858-861,共4页 Cancer Research and Clinic
关键词 抗坏血酸 过氧化氢 肿瘤细胞 Ascorbic acid Hydrogen peroxide Cancer cells
  • 相关文献

参考文献35

  • 1Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA, 1976, 73: 3685-3689.
  • 2Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA, 1978, 75: 4538- 4542.
  • 3Creagan ET, M,rtel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med, 1979, 301: 687-690.
  • 4Moertel CG, Flemin.g TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med, 1985, 312: 137-141.
  • 5Mark L, Michael GE, Chert Q. Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatment. Free Radical Biology &Medicine, 2009, 47: 27-29.
  • 6张科生,黄山鹰.人类抗坏血酸(维生素C)遗传缺陷学说暨人类第一病因学说(上)——五个关于维生素C的重大发现及其对人类健康的深远意义[J].医学与哲学(A),2006,27(7):55-58. 被引量:7
  • 7Bates CJ. The function and metabolism of Vitamin C in man. In: Counsell JN, Horning DH. Vitamirr c-ascorbic acid. London, Applied Science Publishers, 1981 : 1-22.
  • 8葛可佑.中国营养科学全书:上册.北京:人民卫生出版社.2004:10.
  • 9Yi Li, Schellhorn HE. New deve|opments and novel therapeutic perspectives for vitamin C. J Nutr, 2007,137:2171-2184.
  • 10Agus DB, Gambhir SS, Pardridge WM, et al. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest, 1997, 100: 2842-2848.

二级参考文献42

  • 1Zheng QS, Zhang YT, Zheng RL. Ascorbic acid induces redifferentiation and growth inhibition in human hepatoma cells by increasing endogenous hydrogen peroxide[J]. Pharmazie,2002,57(11):753-757.
  • 2Jamison JM,Gilloteaux J,Taper HS,et al.Autoschizis:a novel cell death[J]. Biochem Harmacol,2002,63(10):1773-1783.
  • 3Makino Y, Sakagami H, Takeda M. Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines[J]. Anticancer Res, 1999,19(4B):3125-3132 .
  • 4Ahmed MI,Fayed ST,Hossein H,et al.Lipid peroxidation and antioxidant status in human cervical carcinoma[J].Dis Markers,1999,15(4):283-291 .
  • 5Atalah E,Urteaga C,Rebolledo A,et al.Diet,smoking and reproductive history as risk factor for cervical cancer[J].Rev Med Chil,2001,129(6):597-603.
  • 6Zhang ZW, Abdullahi M, Farthing MJ.Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori[J]. Gut,2002,50(2):165-169.
  • 7Riordan NH,Riordan HD,Meng X,et al.Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent[J].Med Hupotheses Clin Cancer Res,2002,8(12):3658-3668.
  • 8Riordan N,Riordan H,Casciari J.Clinical and experimental experiences with intravenous vitamin C[J].J Orthomolecular Med,2000,15(4): 201-213.
  • 9W. L. Cooke,R. S. Milligan Recurrent Hemoperitoneum Reversed by Ascorbie ACID The Journal of American Medicine Assocation(JAMA)[J]. 1977,237(13):1 358-1 359.
  • 10Frederick Robert Klenner. Significance of High Daily Intake of Ascorbic Acid in Preventive Medicine[J ]. Journal of the International Academy of Preventive Medicine, 1974,1 ( 1 ) :45 - 69.

共引文献30

同被引文献26

  • 1Quievryn G, Messer J, Zhitkovich A. Carcinogenic chromium (VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells [J].Bio- chemistry, 2002, 41(9): 3156-3167.
  • 2Karaczyn A, Ivanov S, Reynolds M, et al. Ascor- bate depletion mediates up-regulation of hypoxia- associated proteins by cell density and nickel [J].J Cell Biochem, 2006, 97(5): 1025-1035.
  • 3Peterson-Roth E, Reynolds M, Quievryn G, et al. Mismatch repair proteins are activators of toxic re- sponses to chromium-DNA damage [J].Mol Cell Bi- ol, 2005, 25(9): 3596-3607.
  • 4Zhitkovieh A. Chromium in drinking water., sources, metabolism, and cancer risks [J].Chem Res Toxicol, 2011, 24(10): 1617-1629.
  • 5Vageli D P, Giannopoulos S, Doukas S G, et al. Mismateh repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium [J]. Oncol Lett, 2013, 5 (1) : 283-294.
  • 6Takahashi Y, Kondo K, Hirose T, et al. Microsat- ellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate- exposed workers [J]. Mol Carcinogen, 2005, 42(3): 150-158.
  • 7Xie H, Wise SS, Wise Sr JP. Deficient repair of par- ticulate hexavalent chromium- induced DNA double strand breaks leads to neoplastic transformation [J]. Mutat Res/Genetic Toxicol Environ Mutagen, 2008, 649(1) .. 230-238.
  • 8Muller A, Fishel R. Mismatch repair and the heredi-tary non- polyposis colorectal cancer syndrome (HNPCC)[J].Cancer Investig, 2002, 20(1): 102- 109.
  • 9Reynolds M, Zhitkovich A. Cellular vitamin C increa- ses chromate toxicity via a death program requiring mismatch repair but not p53 l-J]. Carcinogenesis, 2007, 28(7): 1613-1620.
  • 10Tsao DA, Tseng WC, Chang HR. The expression of RKIP, RhoGDI, galectin, c-Myc and p53 in gastro- intestinal system of Cr (VI)-exposed rats[J].J Appl Toxicol, 2011, 31(8): 730-740.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部